Skip to main content
Equibles

VOYA INVESTMENT MANAGEMENT LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1068837 ATLANTA, GA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,588,145
-$536,906 QoQ
Shares Held
249,763
-4.7% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 215 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. VRDN ranks #41 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 505,219 $250,957,432
2 PTGX
Protagonist Therapeutics, Inc
 571,618 $70,068,932
3 TWST
Twist Bioscience Corp
 671,866 $69,121,573
4 SRRK
Scholar Rock Holding Corp
 890,607 $48,983,385
5 KRYS
Krystal Biotech, Inc.
 124,442 $46,251,357
6 TGTX
Tg Therapeutics, Inc.
 819,253 $45,009,759
7 PTCT
Ptc Therapeutics, Inc.
 539,319 $43,992,249
8 PRAX
Praxis Precision Medicines, Inc.
 122,227 $40,920,376

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,588,145 249,763
2026-03-31 $5,125,051 262,017
2025-12-31 $428,242 13,761
2025-09-30 $276,029 12,791
2025-06-30 $279,767 20,012
2025-03-31 $266,499 19,770
2024-12-31 $410,180 21,397
2024-09-30 $463,167 20,359
2024-06-30 $272,559 20,950
2024-03-31 $262,387 14,985
2023-12-31 $363,333 16,682
2023-09-30 $261,577 17,052
2023-06-30 $398,601 16,755
2023-03-31 $363,715 14,297
2022-12-31 $417,615 14,297
2022-09-30 $213,714 10,420